Latest News


Cardiovascular and Renal Research

Encouraging news for those with chronic kidney disease.

Improved accessibility to a treatment for kidney disease has been welcomed by Kolling Institute researcher and Royal North Shore Hospital clinician Professor Carol Pollock. Forxiga (dapagliflozin), an oral medicine which can help slow the progression of proteinuric chronic kidney disease, has now been listed on the Pharmaceutical Benefits Scheme. The listing aims to help those with the c.....
Read more

Category: Cardiovascular and Renal Research, New Treatment

Researchers to study link between cardiovascular disease and sleep apnoea .

With a disturbing number of people losing their lives to heart disease each year, researchers have launched the first study of its kind using MRI technology to broaden our understanding of the link between cardiovascular disease and sleep apnoea. The project has been made possible following funding from the Ramsay Research Grant Program, and will involve clinician researchers from Northe.....
Read more

Category: Cardiovascular and Renal Research, Research Excellence

Researchers develop test to identify the severity of kidney disease.

We may soon have a safer approach to diagnosing and measuring the progression of chronic kidney disease following new research by the team from the Kolling Institute’s Renal Research Laboratory. The condition is a global health issue, which now affects more than 13 per cent of the worldwide population. Chronic kidney disease is a progressive disease that leads to end-stage kidney failur.....
Read more

Category: Cardiovascular and Renal Research, Research Excellence

Masters players committed to the team, ignore heart health.

Research from the University of Sydney and Royal North Shore Hospital provides insights into cardiac risk among footballers of masters age (35 years and older), an increasingly popular pastime. In what is believed to be the first study to assess cardiac knowledge and beliefs in this higher-risk amateur football group, researchers have found that one in five players experienced one or mor.....
Read more

Category: Cardiovascular and Renal Research, Research Excellence

Study confirms deadly risk of COVID-19 for those with heart failure .

The largest study of its kind in Australia has found patients with a history of heart failure are three times more likely to die from COVID-19. Launched last year at the outset of the pandemic, the AUS-COVID trial is investigating those who are most at risk from COVID-19 in Australia. To date, it has assessed hundreds of patients in 21 hospitals across the country. The study confirmed ea.....
Read more

Category: Cardiovascular and Renal Research, Research Excellence

Life after cardiac arrest.

Just over two years ago, Ian Hutchinson (Hutch) was cycling with a friend on Sydney’s northern beaches, taking part in an activity he regularly enjoyed with his mate. But that morning was to have a life-changing impact, with Hutch suffering a sudden cardiac arrest midway through the ride. It was only the quick thinking of his friend Don MacKee and a group of bystanders who called triple .....
Read more

Category: Cardiovascular and Renal Research

Kolling researchers identifying COVID-19 impact on heart health.

The largest study of its type in Australia will investigate the impact of COVID-19 on younger patients with new trends emerging around the cardiac complications from the Delta strain of the virus. Launched last year, the AUS-COVID trial assessed more than 640 patients in 21 hospitals across Australia, recording cardiovascular complications. From this group, 125 were people were admitted .....
Read more

Category: Cardiovascular and Renal Research, Research Excellence

Recognition for a remarkable career.

Kolling Institute researcher and Royal North Shore Hospital clinician Professor Carol Pollock has been recognised for her extraordinary contribution to healthcare in this year’s Queen’s birthday honour roll. Professor Pollock has been appointed an officer of the order of Australia for her distinguished service to medical research, education and science, nephrology, and clinical practice .....
Read more

Category: Awards, Cardiovascular and Renal Research, Research Excellence

Kolling researchers join global effort to reduce heart disease in women.

Two leading cardiovascular experts have been appointed to a prestigious world expert panel to reduce rates of cardiovascular disease in women. Royal North Shore Hospital (RNSH) interventional cardiologist and Kolling Institute researcher, Professor Gemma Figtree, and RNSH senior hospital scientist and Kolling Institute researcher, Dr Anastasia Mihailidou, have been appointed commissioner.....
Read more

Category: Cardiovascular and Renal Research

Researchers drive global call to action to tackle world’s leading cause of death.

A team of researchers from the Kolling Institute, The University of Sydney, Monash University and La Trobe University have led a global call to action to accelerate new approaches for cardiovascular disease (CVD) drug solutions. CVD is the leading cause of death globally. Since the start of the pandemic approximately 18 million people have died of CVD, with the majority from low- and mid.....
Read more

Category: Cardiovascular and Renal Research